UPDATE 1-Spectrum Pharma's cancer drug meets main goal in trial

April 23 (Reuters) - Spectrum Pharmaceuticals Inc said its experimental blood cancer drug was shown to be safe and effective in a mid-stage trial, sending its shares up 10 percent.